Loading…
Loading…
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s share price passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $11.98 and traded as low as $10.00. Cipher Pharmaceuticals shares last traded at $10.19, with a volume of 9,491 shares. Cipher
Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript
WASHINGTON--(BUSINESS WIRE)-- #DTP--CaryHealth, a leading digital health company, today announced the launch of its direct-to-patient (DTP) platform to support seamless access to Natroba (spinosad), a prescription treatment for head lice and scabies, in partnership with Cipher Pharmaceuticals US LLC (Cipher or Cipher Pharmaceuticals). Through this partnership, CaryHealth has designed an online custom platform to both access and quickly deliver Natroba (spinosad) to patients, which eliminates common ob.
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $11.18 and traded as high as $13.28. Cipher Pharmaceuticals shares last traded at $13.00, with a volume of 8,501 shares traded. Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. (CPH:CA) Q4 2025 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s stock price passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $10.40 and traded as high as $10.90. Cipher Pharmaceuticals shares last traded at $10.90, with a volume of 2,734 shares. Cipher Pharmaceuticals Trading
Cipher Pharmaceuticals Inc. ( CPH:CA ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Craig Mull - Interim CEO & Chairman of the Board Ryan Mailling - Chief Financial Officer Bryan Jacobs - President Conference Call Participants Andre Uddin - Research Capital Corporation, Research Division Douglas W. Loe - Leede Financial Inc., Research Division Tania Gonsalves - Canaccord Genuity Corp., Research Division Presentation Operator Good morning, ladies and gentlemen.
FILA declined during the quarter as a result of an analyst downgrade amidst an uncertain US outlook. During the quarter NLOP paid its first, and hopefully many more, special dividend of $3.10/share totalling $46m. Mestek Inc. is a new position and last year they did $400m in revenue and $34m in operating earnings.
No recent filings indexed.